Cargando…

An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells

Advances in the understanding of the infection and reactivation process of herpes simplex type 1 (HSV-1) are generally gained by monolayer cultures or extensive and cost-intensive animal models. So far, no reliable in vitro skin model exists either to investigate the molecular mechanisms involved in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogk, Ina, Kaufmann, Michaela, Finkelmeier, Doris, Rupp, Steffen, Burger-Kentischer, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731678/
https://www.ncbi.nlm.nih.gov/pubmed/23914331
http://dx.doi.org/10.1089/biores.2013.0019
_version_ 1782279186592825344
author Hogk, Ina
Kaufmann, Michaela
Finkelmeier, Doris
Rupp, Steffen
Burger-Kentischer, Anke
author_facet Hogk, Ina
Kaufmann, Michaela
Finkelmeier, Doris
Rupp, Steffen
Burger-Kentischer, Anke
author_sort Hogk, Ina
collection PubMed
description Advances in the understanding of the infection and reactivation process of herpes simplex type 1 (HSV-1) are generally gained by monolayer cultures or extensive and cost-intensive animal models. So far, no reliable in vitro skin model exists either to investigate the molecular mechanisms involved in controlling latency and virus reactivation or to test pharmaceuticals. Here we demonstrate the first in vitro HSV-1 reactivation model generated by using the human keratinocyte cell line HaCaT grown on a collagen substrate containing primary human fibroblasts. We integrated the unique feature of a quiescently infected neuronal cell line, the rat pheochromocytoma line PC12, within the dermal layer of the three-dimensional skin equivalent. Transmission electron microscopy, a cell-based TCID(50) assay, and polymerase chain reaction analysis were used to verify cell latency. Thereby viral DNA could be detected, whereas extracellular as well as intracellular virus activity could not be found. Further, the infected PC12 cells show no spontaneous reactivation within the in vitro skin equivalent. In order to simulate a physiologically comparable HSV-1 infection, we achieved a specific and pointed reactivation of quiescently HSV-1 infected PC12 cells by UVB irradiation at 1000 mJ/cm(2).
format Online
Article
Text
id pubmed-3731678
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-37316782013-08-02 An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells Hogk, Ina Kaufmann, Michaela Finkelmeier, Doris Rupp, Steffen Burger-Kentischer, Anke Biores Open Access Original Research Articles Advances in the understanding of the infection and reactivation process of herpes simplex type 1 (HSV-1) are generally gained by monolayer cultures or extensive and cost-intensive animal models. So far, no reliable in vitro skin model exists either to investigate the molecular mechanisms involved in controlling latency and virus reactivation or to test pharmaceuticals. Here we demonstrate the first in vitro HSV-1 reactivation model generated by using the human keratinocyte cell line HaCaT grown on a collagen substrate containing primary human fibroblasts. We integrated the unique feature of a quiescently infected neuronal cell line, the rat pheochromocytoma line PC12, within the dermal layer of the three-dimensional skin equivalent. Transmission electron microscopy, a cell-based TCID(50) assay, and polymerase chain reaction analysis were used to verify cell latency. Thereby viral DNA could be detected, whereas extracellular as well as intracellular virus activity could not be found. Further, the infected PC12 cells show no spontaneous reactivation within the in vitro skin equivalent. In order to simulate a physiologically comparable HSV-1 infection, we achieved a specific and pointed reactivation of quiescently HSV-1 infected PC12 cells by UVB irradiation at 1000 mJ/cm(2). Mary Ann Liebert, Inc. 2013-08 /pmc/articles/PMC3731678/ /pubmed/23914331 http://dx.doi.org/10.1089/biores.2013.0019 Text en Copyright 2013, Mary Ann Liebert, Inc.
spellingShingle Original Research Articles
Hogk, Ina
Kaufmann, Michaela
Finkelmeier, Doris
Rupp, Steffen
Burger-Kentischer, Anke
An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells
title An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells
title_full An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells
title_fullStr An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells
title_full_unstemmed An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells
title_short An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells
title_sort in vitro hsv-1 reactivation model containing quiescently infected pc12 cells
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731678/
https://www.ncbi.nlm.nih.gov/pubmed/23914331
http://dx.doi.org/10.1089/biores.2013.0019
work_keys_str_mv AT hogkina aninvitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT kaufmannmichaela aninvitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT finkelmeierdoris aninvitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT ruppsteffen aninvitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT burgerkentischeranke aninvitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT hogkina invitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT kaufmannmichaela invitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT finkelmeierdoris invitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT ruppsteffen invitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells
AT burgerkentischeranke invitrohsv1reactivationmodelcontainingquiescentlyinfectedpc12cells